Delhi: Counterfeit Thrombophob Ointments worth over Rs 2.5 Lakh seized following Zydus Healthcare complaint

Written by Ruchika Sharma Published On 2025-04-15T12:49:58+05:30 | Updated On 15 April 2025 12:49 PM IST

Delhi: Counterfeit Thrombophob Ointments worth over Rs 2.5 Lakh seized following Zydus Healthcare complaint

New Delhi: Acting on a complaint filed by pharmaceutical major Zydus Healthcare Limited, the Drugs Control Department of the Delhi government has seized counterfeit Thrombophob ointments worth more than Rs 2.5 lakh from a wholesale drug outlet in the Capital, officials has said.

Thrombophob ointment is a medication widely used in the treatment of thrombophlebitis, a vein inflammation condition due to blood clots. When applied topically, the drug helps reduce pain, inflammation, and promotes faster healing.

According to officials, Zydus Healthcare, the original manufacturer of Thrombophob 20g ointment (comprising Heparin Sodium and Benzyl Nicotinate), alerted authorities of the circulation of counterfeit versions of the drug in the Delhi market.

The department's intelligence cell developed the input further, leading to the identification of a suspected wholesaler operating from the Chandni Chowk area, PTI reported.

A team from the Drugs Control Department of Delhi was constituted under the directions of Drugs Controller Danish Ashraf, IAS.

The team, led by a Deputy Drugs Controller and comprising Assistant Drugs Controllers and several Drugs Inspectors, conducted a surprise raid on Wednesday at the premises of a wholesale medicine dealer operating under the name Kyara Pharmaceutical in Bhagirath Palace, the statement read.

During the inspection, officials found 1,408 tubes of Thrombophob 20g ointment labelled.

Physical examination and QR code scanning -- a traceability feature mandated by the Government of India for the top 300 brands since August 1, 2023 -- confirmed that the QR codes were fake and not aligned with manufacturer-generated data.

As per procedures outlined in the Drugs and Cosmetics Act, 1940, on-site samples were collected, and 1,288 tubes were seized. The total estimated market value of the seized stock is over Rs 2.5 lakh, the statement read.

Further investigation in the case is underway, it read.

thrombophob ointmentthrombophlebitisblood clotzydus healthcarekyara pharma

Source : with inputs

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751